Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE-170 phase 2 trial
Autor: | M. D. Caballero Barrigón, Beth Christian, Catherine Thieblemont, Zafer Gulbas, P. Armand, Arkendu Chatterjee, A. Majlis, Arun Balakumaran, Muhit Ozcan, P. L. Zinzani, Margaret A. Shipp, Gilles Salles, Dzhelil Osmanov, Laura Fogliatto, Jan Walewski, Kamal Bouabdallah, V. Melnichenko, S. Chlosta |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Oncology Cancer Research medicine.medical_specialty business.industry Hematology General Medicine Pembrolizumab Interim analysis 03 medical and health sciences 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine Relapsed refractory medicine Primary Mediastinal Large B-Cell Lymphoma business |
Zdroj: | Hematological Oncology. 35:62-63 |
ISSN: | 0278-0232 |
Databáze: | OpenAIRE |
Externí odkaz: |